Reduction of Hepatitis A Virus on FRhK‐4 Cells Treated with Korean Red Ginseng Extract and Ginsenosides
Authors:
- 9 August 2013
- journal article
- Published by Wiley in Journal of Food Science
- Vol. 78 (9) , M1412-M1415
Abstract
Red ginseng has a variety of bioactive functions and is widely used as an oriental medicinal herb and food ingredient. The aim of this study was to investigate the antiviral effect of red ginseng extract and ginsenosides against hepatitis A virus (HAV). To examine the antiviral effect against HAV, 0 to 10 μg/mL of red ginseng and purified ginsenoside Rb1 and Rg1 were pre‐treated or co‐treated on FRhK‐4 cells. The HAV titer decreased significantly in all groups pretreated with red ginseng or purified ginsenosides. The reduction of HAV was significant in FRhK‐4 cells pre‐treated only with red ginseng. Our results showed that red ginseng and ginsenoside Rg1 and Rb1 could decrease HAV titers.Keywords
This publication has 30 references indexed in Scilit:
- Changing Pattern of Hepatitis A Virus Epidemiology in an Area of High EndemicityHepatitis Monthly, 2012
- Protective Effect of Ginseng Polysaccharides on Influenza Viral InfectionPLOS ONE, 2012
- Molecular Mechanism of Macrophage Activation by Red Ginseng Acidic Polysaccharide from Korean Red GinsengMediators of Inflammation, 2012
- Antiviral Effect of Korean Red Ginseng Extract and Ginsenosides on Murine Norovirus and Feline Calicivirus as Surrogates for Human NorovirusJournal of Ginseng Research, 2011
- Grape Seed Extract for Control of Human Enteric VirusesApplied and Environmental Microbiology, 2011
- In Vitro Effects of Pomegranate Juice and Pomegranate Polyphenols on Foodborne Viral SurrogatesFoodborne Pathogens and Disease, 2010
- Epidemiology of hepatitis A in Finland in 1990–2007Journal of Medical Virology, 2010
- Beneficial Effects of a Combination of Korean Red Ginseng and Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected PatientsClinical and Vaccine Immunology, 2009
- Tumor Necrosis Factor-α Regulates Cyclin-dependent Kinase 5 Activity during Pain Signaling through Transcriptional Activation of p35Journal of Biological Chemistry, 2009
- Antiviral activity of recombinant interferon-α on hepatitis A virus replication in human liver cellsAntiviral Research, 1995